| Dr Emerson Jay Mounger, MD MEDICAL DOCTOR | |
|
1932 Alcoa Hwy, Suite C 475, Knoxville, TN 37920-1523 | |
| (865) 305-5000 | |
| (865) 305-5001 |
| Full Name | Dr Emerson Jay Mounger |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1932 Alcoa Hwy, Knoxville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679648398 | NPI | - | NPPES |
| 4024485 | Other | TN | BCBS |
| 3150382 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD0000004719 (Tennessee) | Primary |
| Entity Name | Urology And Urologic Surgery Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962532515 PECOS PAC ID: 4183720352 Enrollment ID: O20070503000679 |
News Archive
AstraZeneca announced today that the U.S. Food and Drug Administration has approved the use of NEXIUM I.V. for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease with erosive esophagitis when oral therapy is not possible or appropriate.
Tao Weitao, a researcher in the College of Sciences' Department of Biology at the University of Texas at San Antonio is making great strides in a project that was funded one year ago by the San Antonio Area Foundation. The professor in the South Texas Center for Emerging Infectious Diseases is researching Acinetobacter baumannii, a soil-dwelling bacterium that threatens the health of military personnel in the Middle East and can also infect their family members once the soldiers have returned home following battle.
A high-fat diet can be bad for your health. However, a snack-based "cafeteria"-style diet of highly palatable, energy-dense foods is even worse, according to new research.
Additional study results from 12 hemophilia A and B subjects demonstrated that subcutaneous administration of ALN-AT3 achieved potent and dose-dependent knockdown of AT of up to 86%. AT knockdown was highly durable, with effects lasting over two months after the last dose, supporting further evaluation of a once-monthly subcutaneous dose regimen.
OrthoSensor, Inc., the leader in Sensor-Assisted Surgery, announced today that it has raised $19 million in a private placement of Series C Preferred Stock. Bridger Healthcare, Ltd. and The Tullis Growth Fund, L.P. participated in the round. The proceeds will be used to drive the commercialization of VERASENSE, OrthoSensor's leading product, and expand product development activities.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emerson Jay Mounger, MD MEDICAL DOCTOR 1932 Alcoa Hwy, Suite 475 Building C, Knoxville, TN 37920-1523 Ph: (865) 305-5000 | Dr Emerson Jay Mounger, MD MEDICAL DOCTOR 1932 Alcoa Hwy, Suite C 475, Knoxville, TN 37920-1523 Ph: (865) 305-5000 |
News Archive
AstraZeneca announced today that the U.S. Food and Drug Administration has approved the use of NEXIUM I.V. for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease with erosive esophagitis when oral therapy is not possible or appropriate.
Tao Weitao, a researcher in the College of Sciences' Department of Biology at the University of Texas at San Antonio is making great strides in a project that was funded one year ago by the San Antonio Area Foundation. The professor in the South Texas Center for Emerging Infectious Diseases is researching Acinetobacter baumannii, a soil-dwelling bacterium that threatens the health of military personnel in the Middle East and can also infect their family members once the soldiers have returned home following battle.
A high-fat diet can be bad for your health. However, a snack-based "cafeteria"-style diet of highly palatable, energy-dense foods is even worse, according to new research.
Additional study results from 12 hemophilia A and B subjects demonstrated that subcutaneous administration of ALN-AT3 achieved potent and dose-dependent knockdown of AT of up to 86%. AT knockdown was highly durable, with effects lasting over two months after the last dose, supporting further evaluation of a once-monthly subcutaneous dose regimen.
OrthoSensor, Inc., the leader in Sensor-Assisted Surgery, announced today that it has raised $19 million in a private placement of Series C Preferred Stock. Bridger Healthcare, Ltd. and The Tullis Growth Fund, L.P. participated in the round. The proceeds will be used to drive the commercialization of VERASENSE, OrthoSensor's leading product, and expand product development activities.
› Verified 2 days ago
Dr. Robert W Hatfield, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2001 Laurel Ave, Suite 502, Knoxville, TN 37916 Phone: 865-331-9000 Fax: 865-331-7000 | |
Walter W Chiles Iii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9245 Park West Blvd, Knoxville, TN 37923 Phone: 865-690-3811 Fax: 865-694-7621 | |
Dr. Edward B Tieng, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2001 Laurel Ave, Suite 502, Knoxville, TN 37916 Phone: 865-331-9000 Fax: 865-331-7000 | |
Dr. Renee Bailey Quillin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2001 Laurel Ave Ste 508, Knoxville, TN 37916 Phone: 865-331-9000 Fax: 865-331-7000 | |
Leor T Arbel, MD Urology Medicare: Medicare Enrolled Practice Location: 10800 Parkside Dr Ste 330, Knoxville, TN 37934 Phone: 865-647-1876 Fax: 865-471-2246 | |
Dr. Arthur Scott Klein, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 4123 Kirkstone Ln, Knoxville, TN 37918 Phone: 608-769-3735 | |
Christopher D Harris, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9245 Park West Blvd, Knoxville, TN 37923 Phone: 865-690-3811 Fax: 865-694-7621 |